USFDA 483 / Intas / May 2023 /Manipulati
USFDA483 to Intas cites manipulated visual inspection reports; failure to characterise particles observed in injection
Discussion forum for Pharma Quality events, Regulatory Actions
Warning letters, 483s, Recalls, Import Alerts, Audit observations
